4th Applied Biocatalysis and Enzyme Engineering Summit

Memo

Welcome to a pivotal moment in the Golden Age of Biocatalysis, where industry leaders like Eli Lilly and Pfizer are transforming small molecule operations and biopharma is pushing the boundaries of biologics development. This year, we're witnessing ground breaking advancements as biocatalysis becomes central to biologics and therapeutic innovation. In collaboration with Merck, Novo Nordisk and Pfizer, we're excited to bring you the 4th Applied Biocatalysis and Enzyme Engineering Summit - now with a sharper focus on enzyme engineering and expanded coverage of biocatalysis-derived oligonucleotides, peptides and other large biologics. Plus, dive into brand-new biopharma case studies designed to boost enzyme efficiency and therapeutic yields. Why Attend? - Revolutionize Biologics Development: Discover cutting-edge oligonucleotide production case studies that are setting new standards in biologics - Streamline Enzyme Discovery: Learn how to prioritize and engineer enzymes from early-stage proof of concept to accelerate your pipeline - Fast-Track Decision Making: Master modern prediction methods and sophisticated high-throughput techniques to refine enzyme selection - Optimize Small Molecule Biocatalysis: Gain insights from pharma-led projects focused on enhancing activity, yields and green chemistry Join over 80 enzyme engineering, biocatalysis and process chemistry professionals from both industry and academia. Let's innovate and elevate drug development pipelines together through the power of green biocatalysis. URLs:Tickets: https://go.evvnt.com/2612062-2?pid=5569Brochure: https://go.evvnt.com/2612062-3?pid=5569 Date and Time: Tuesday, 10 December 2024 at 09:00 to Thursday, 12 December 2024 at 16:00 Venue details: Loews Philadelphia Hotel, 1200 Market Street, Philadelphia, Pennsylvania, 19107, United States Category: Conferences | Science, Health and Medicine | Pharmaceuticals Prices:Industry Pricing - All Access Pass (Conference + 2 Workshops): USD 4197.00,Industry Pricing - (Conference + 1 Workshop): USD 3598.00,Industry Pricing - (Conference Only): USD 2999.00,Academic and Not-for-Profit Pricing - All Access Pass (Conference + 2 Workshops): USD 3597.00,Academic and Not-for-Profit Pricing - (Conference + 1 Workshop): USD 3098.00,Academic and Not-for-Profit Pricing - (Conference Only) - : USD 2599.00,Solution Provider Pricing - All Access Pass (Conference + 2 Workshops): USD 5097.00,Solution Provider Pricing - All Access Pass (Conference + 1 Workshop): USD 4398.00,Solution Provider Pricing - All Access Pass (Conference Only): USD 3699.00 Speakers: Aditya Kunjapur, Assistant Professor, University of Delaware, Adrian Ortiz, Director Of Process Development, Amgen, Carlos Martinez, Director - Biocatalysis Center of Excellence, Pfizer, Deeptak Verma, Director of Computational Chemistry, Merck, Gabriel Lovinger, Assistant Professor – Chemistry, Purdue University, Jan Grunewald, Associate Director, AstraZeneca, Jason Tedrow, Head of Process Chemistry, Sanofi, Jennifer Kennemur, Postdoctoral Research Fellow, California Institute of Technology, Jesse Brown, Scientist I, AbbVie, Jessica Hurtak, Senior Scientist, Boehringer Ingelheim, Kaitlyn Gray, Senior Principal Scientist in Process Chemistry, Pfizer, Lara Zetzsche, Senior Scientist, Amgen, Michael Delaney, Principal Scientist CMC, Novo Nordisk, Roumen Radinov, Vice President, Process Sciences, Alnylam Pharmaceuticals, Rudi Fasan, Chair in Chemistry, The University of Texas at Dallas, Scott France, Associate Principal Scientist- Biocatalysis, Merck, Shuvendu Das, Research Leader, The University of Iowa, Yinchen Tan, Senior Principal Scientist, Bristol Myers Squibb, Zhongyue Yang, Assistant Professor of Chemistry, Vanderbilt University